# Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy

> **NCT05513937** · PHASE4 · COMPLETED · sponsor: **Menarini International Operations Luxembourg SA** · enrollment: 301 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT05513937
- **Lead sponsor:** Menarini International Operations Luxembourg SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-12
- **Primary completion:** 2022-11-15
- **Final completion:** 2022-11-15
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05513937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05513937, "Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05513937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*